BlackRock, Inc. 13D and 13G filings for Anavex Life Sciences Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 5:01 pm Purchase | 2023-12-31 | 13G | Anavex Life Sciences Corp. AVXL | BlackRock Inc. BLK | 6,671,075 8.100% | 1,092,916 (+19.59%) | Filing |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Anavex Life Sciences Corp. AVXL | BlackRock Inc. BLK | 5,578,159 7.200% | 315,493 (+5.99%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Anavex Life Sciences Corp. AVXL | BlackRock Inc. BLK | 5,262,666 6.900% | 1,583,903 (+43.06%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Anavex Life Sciences Corp. AVXL | BlackRock Inc. BLK | 3,678,763 5.500% | 768,542 (+26.41%) | Filing |